Neurosciences Research

At Houston Methodist, our teams are dedicated to the development of new treatments and therapies for such neurological challenges as stroke, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), myasthenia gravis, brain tumors, concussion, spinal disorders, brain aneurysms, arteriovenous malformations, moyamoya disease, stuttering, Tourette’s syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). 

We concentrate our investigations on meaningful translational research that broadens our understanding of the major neurological challenges of brain, pituitary tumors, brain microcirculation in normal and pathological conditions, neurodegenerative and neuromuscular diseases, computational hemodynamics (simulating blood flow in cerebral aneurysms), functional magnetic resonance imaging, speech disorder and developmental learning disability modeling.


A Houston Methodist study showed promising results for patients with ALS, also know as Lou Gehrig's disease. Learn more

Gavin Britz, MBBCh, MPH, MBA, describes how virtual reality is helping him better plan neurosurgery procedures and leading to safer surgeries. Learn more

Houston Methodist researchers led by Muralidhar Hegde, PhD, and Haibo Wang, PhD, have discovered a repair defect in nerve cells that send messages to the brain, opening the door to a possible therapy for preventing or slowing down ALS. Learn more>

Stan Appel

Stanley H. Appel, MD is the Peggy and Gary Edwards Distinguished Endowed Chair for the Treatment and Research of ALS, Professor of Neurology, and Co-Director of the Houston Methodist Neurological Institute. Learn More.

Live Chat Available